Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

ORCHID PHARMA LTD.

NSE : ORCHPHARMABSE : 524372ISIN CODE : INE191A01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE1864.70-118.1 (-5.96 %)
PREV CLOSE () 1982.80
OPEN PRICE () 1932.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13902
TODAY'S LOW / HIGH ()1797.05 1988.95
52 WK LOW / HIGH ()702.3 1998
NSE1868.45-114.05 (-5.75 %)
PREV CLOSE() 1982.50
OPEN PRICE () 1952.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1868.45 (8)
VOLUME 147593
TODAY'S LOW / HIGH() 1799.05 1984.00
52 WK LOW / HIGH ()702.75 1997.4
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1992

Management Info :

Ram Gopal Agarwal - Chairman Manish Dhanuka - Managing Director

Registered Office :

Address : Plot Nos. 121-128, 128 A-133, 138-151, 159-164,Sidco Industrial Estate,Alathur,
Chengalpattu,
Tamil Nadu-603110

Phone : 044-44-2744 4471/72/73

Registrar's Details : Abhipra Capital Ltd
Abhipra Complex,A-387 Azadpur,Dilkush Indl.Area G T Karnal Road ,New Delhi
Listing : BSE, NSE
NEWS
12Nov Orchid Pharma informs about newspaper
In accordance to Regulation 47 of Securities and Exchange Board of India..
07Aug Orchid Pharma submits analyst meet int
Orchid Pharma has informed that pursuant to Regulation 30 read with Para..
01Jul Orchid Pharma gains on partnering with
Orchid Pharma is currently trading at Rs. 1150.35, up by 10.50 points or..
28Jun Orchid Pharma partners with Cipla to l
Orchid Pharma has launched its new drug - Cefepime-Enmetazobactam, which..
06Jun Orchid Pharma gets DCGI’s approval for
Orchid Pharma has received Drugs Controller General of India (DCGI) appr..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit256.27947.49
Gross Profit 256.27 915.23
Operating Profit 375.481410.7
Net Sales 2226.998193.68
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 29939.60 (1.58%)
M.Cap ( in Cr)
63619.56
Astrazeneca Pharma I (BSE)
 7251.75 (1.94%)
M.Cap ( in Cr)
18129.38
Ajanta Pharma (BSE)
 2948.80 (2.70%)
M.Cap ( in Cr)
36834.08
Concord Biotech (BSE)
 2158.60 (3.38%)
M.Cap ( in Cr)
22582.45
Alkem Laboratories (BSE)
 5524.45 (0.44%)
M.Cap ( in Cr)
66053.09
Shareholding Pattern
PROMOTERS 69.84%
MUTUAL FUNDS/UTI 16.78%
NON-INSTITUTION 9.93%
FI/BANKS/INSURANCE 0.93%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77964.99-1258.12 (-1.59%)
NIFTY23616.05-388.70 (-1.62%)
Dow Jones 42732.13339.86 (0.80%)
Nasdaq 19621.68340.89 (1.77%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI